Stocktoria
enVVeno Medical Corp NVNO
Nasdaq · XNAS · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2018-05-31
enVVeno Medical Corp financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| R&D expense | $10.0M | $12.2M | $13.6M | $9.9M | $5.7M |
| SG&A expense | $10.9M | $11.6M | $11.7M | $15.0M | $11.2M |
| Operating income | -$20.9M | -$23.8M | -$25.2M | -$24.9M | -$16.9M |
| Net income | -$19.5M | -$21.8M | -$23.5M | -$24.7M | -$16.5M |
| EPS (diluted) | $-33.06 | $-44.53 | $-1.91 | $-2.20 | — |
| Operating cash flow | -$15.6M | -$16.8M | -$18.9M | -$15.6M | -$11.8M |
| Free cash flow | -$15.6M | -$16.9M | -$18.9M | -$15.7M | -$12.2M |
| Cash & equivalents | $3.1M | $1.8M | $3.6M | $4.6M | $54.7M |
| Total assets | $29.6M | $45.0M | $48.6M | $41.7M | $57.7M |
| Total liabilities | $2.4M | $2.8M | $2.4M | $2.9M | $3.3M |
| Shareholders' equity | $27.1M | $42.2M | $46.2M | $38.7M | $54.4M |
Source: SEC EDGAR filings · CIK 0001661053 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.